Patient Details
| Patient no. | Age (y) | PSA at PET (ng/mL) | ISUP grade group | pTNM | R | Previous treatments | Positive on Pre-SLND PET | Positive on SLND (histopathology) | Positive on post-SLND PET | Pre- to post-PET diagnosis |
| 1 | 53 | 0.4 | 4 | pT3b pN1 | R0 | RP | T0N1(IIR)M0 | IR | T0N1(IIR)M0 | Persistence |
| 2 | 68 | 0.4 | 2 | pT2c pN0 | R0 | RP | T0N1(OL)M0 | OL | T0N0M0 | No disease |
| 3 | 65 | 0.5 | 5 | pT3a pN1 | R0 | RP | T0N1(OL,IIL)M0 | PS/MR | T0N1(OL,IIL)M0 | Persistence |
| 4 | 63 | 0.8 | 5 | pT3b | n/a | RP | T0N1(IIL)M0 | IIL, CIL | T0N1(CIL,EIL)M0 | New lesion/recurrence |
| 5 | 67 | 1.0 | 3 | pT2c pN0 | R0 | RP | T0N1(OL,IIL)M0 | IIL | T0N1(CIL,OL,IIL)M0 | Persistence |
| 6 | 75 | 1.1 | 2 | pT2c pN0 | R0 | RP, S-RT | T0N1(EIL)M0 | EIL | T0N0M0 | No disease |
| 7 | 82 | 1.1 | 4 | pT3b pN0 | R1 | RP, S-RT | TrN1(EIR,EIL,OL)M0 | Negative | T0N1(CIR,EIR,EIL)M0 | Persistence |
| 8 | 55 | 1.3 | 5 | pT3b pN1 | R0 | RP | T0N0M1b(uni) | Negative | T0N0M1b(uni) | Persistence |
| 9 | 58 | 1.8 | 5 | pT3b pN1 | n/a | RP | T0N0M1a(retrop) | EIL,CIL | TrN1(CIL)M0 | New lesion/recurrence |
| 10 | 63 | 2.0 | 5 | pT3b pN1 | R0 | RP, ADT | T0N1(CIL,EIL,IIL)M0 | CIL, EIL, IIL | T0N0M1a(retrop) | New lesion/recurrence |
| 11 | 75 | 2.1 | 5 | pT3b pN0 | R1 | RP | T0N1(EIL,OL,IIR)M1a(INR) | IIR | T0N1(EIL,OL,IIR,PS/MR)M1a(retrop,INR) | Persistence |
| 12 | 69 | 3.5 | 3 | pT3a | R1 | RP, S-RT | T0N0M1a(retrop) | n/a | T0N0M1a(retrop) | Persistence |
| 13 | 83 | 3.6 | 4 | pT3a pN0 | n/a | RP | T0N0M0 | PS/MR | T0N1(IIR)M0 | New lesion/recurrence |
| 14 | 49 | 4.2 | 5 | pT3b pN1 | R1 | RP, S-RT; ADT | T0N1(CIL,EIR,IIR,PS/MR)M1a(retrop) | CIL, IIR, retrop | T0N1(CIR,IIR,PS/MR)M1a(retrop) | Persistence |
| 15 | 74 | 12.0 | 4 | pT3b | R0 | RP | TrN1(CIR,EIR,PS/MR)M1a(retrop) | EIR | T0N1(CIR,PS/MR)M0 | Persistence |
| 16 | 60 | 0.5 | 3 | pT2a pN0 | R1 | RP | T0N1M0 | Negative | T0N1M0 | Persistence |
ISUP = International Society of Urologic Pathologists; RP = radical prostatectomy; S-RT = salvage radiotherapy; ADT = androgen deprivation therapy; retrop = retroperitoneal; n/a = not available.
Stage is given in accordance with PROMISE (12).